A cell-based screening system for influenza A viral RNA transcription/replication inhibitors.
A cell-based screening system for influenza A viral RNA transcription/replication inhibitors.
复制标题
DOI:
10.1038/srep01106
复制
发表时间:
2013
影响因子:
4.6
通讯作者:
Kawaoka, Yoshihiro
中科院分区:
文献类型:
--
作者:
Ozawa, Makoto;Shimojima, Masayuki;Goto, Hideo;Watanabe, Shinji;Hatta, Yasuko;Kiso, Maki;Furuta, Yousuke;Horimoto, Taisuke;Peters, Noel R.;Hoffmann, F. Michael;Kawaoka, Yoshihiro
Although two classes of antivirals, NA inhibitors and M2 ion channel blockers, are licensed for influenza treatment, dual resistant mutants, including highly pathogenic H5N1 viruses, have appeared. Alternative treatment options are, therefore, needed. Influenza A viral RNA (vRNA) transcription/replication is a promising target for antiviral development, since it is essential for virus replication. Accordingly, an efficient and reliable method to identify vRNA transcription/replication inhibitors is desirable. Here, we developed a cell-based screening system by establishing a cell line that stably expresses influenza viral ribonucleoprotein complex (vRNP). Compound library screening using this cell line allowed us to identify a compound that inhibits vRNA transcription/replication by using reporter protein expression from virus-like RNA as a readout and virus replication in vitro. vRNP-expressing cells have potential as a simple and convenient high-throughput screening (HTS) system, and, thus, are promising to identify vRNA transcription/replication inhibitors for various RNA viruses, especially for primary screens.
登录
查看更多内容
影响因子:
3.7
作者:
Chase, Geoffrey;Deng, Tao;Brownlee, George
通讯作者:
Brownlee, George
DOI:
10.1098/rstb.2001.1007
发表时间:
2001-12-29
影响因子:
6.3
作者:
Hayden, FG
通讯作者:
Hayden, FG
影响因子:
2.7
作者:
NAKAMURA, Y;ODA, K;NAKADA, S
通讯作者:
NAKADA, S
影响因子:
5.4
作者:
Groseth, A;Feldmann, H;Flick, R
通讯作者:
Flick, R
影响因子:
6.1
作者:
Céspedes, CL;Calderón, JS;Aranda, E
通讯作者:
Aranda, E